Skip to content
10-Q

Quarterly Report

SANARA MEDTECH INC. SMTI

0001641172-25-010254

← back to feed
Filed
May 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 13, 2025 8.89M sh
Long Term Debt Q1 2025 · Mar 31, 2025 $43.4M
Long Term Debt Q1 2025 · Dec 31, 2024 $30.69M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $20.69M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $15.88M
Stockholders Equity Q1 2025 · Mar 31, 2025 $36.67M
Stockholders Equity Q1 2025 · Dec 31, 2024 $39.4M
Current Liabilities Q1 2025 · Mar 31, 2025 $13.28M
Current Liabilities Q1 2025 · Dec 31, 2024 $15.29M
Total Liabilities Q1 2025 · Mar 31, 2025 $59.71M
Total Liabilities Q1 2025 · Dec 31, 2024 $49.18M
Current Assets Q1 2025 · Mar 31, 2025 $36.84M
Current Assets Q1 2025 · Dec 31, 2024 $33.31M
Total Assets Q1 2025 · Mar 31, 2025 $96.38M
Total Assets Q1 2025 · Dec 31, 2024 $88.09M
Shares Diluted Q1 2025 · Mar 31, 2024 8.42M sh
Capex Q1 2025 · Mar 31, 2024 $65.82K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$1.59M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.21
Eps Basic Q1 2025 · Mar 31, 2024 −$0.21
Sga Expense Q1 2025 · Mar 31, 2024 $16.19M
Rd Expense Q1 2025 · Mar 31, 2024 $946.3K
Net Income Q1 2025 · Mar 31, 2024 −$1.76M
Operating Income Q1 2025 · Mar 31, 2024 −$1.53M
Gross Profit Q1 2025 · Mar 31, 2024 $16.65M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $1.89M
Revenue Q1 2025 · Mar 31, 2024 $18.54M